Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies
Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies
复制标题
龙血素 A 通过减弱 Akt 磷酸化的抗血小板活性:体外研究
DOI:
10.1016/j.ejphar.2014.10.059
复制
发表时间:
2015-01-05
影响因子:
5
通讯作者:
Ming, Zhang-Yin
中科院分区:
文献类型:
--
作者:
Hao, Hong-Zhen;He, Ao-Di;Ming, Zhang-Yin
Loureirin A is a flavonoid extracted from Dragon's Blood that has been used to promote blood circulation and remove stasis in Chinese traditional medicine. However, the mechanisms of these effects are not fully understood. We explored the anti-platelet activity and underlying mechanism of loureirin A in vitro. Our results indicated that loureirin A negatively affected agonist-induced platelet aggregation such as collagen, collagen-related peptide (CRP), ADP and thrombin. Loureirin A inhibited collagen-induced platelet ATP secretion and thrombin-stimulated P-selectin expression in a dose-dependent manner. Platelet spreading on immobilized fibrinogen was significantly impaired in the presence of loureirin A Immunoblotting analysis indicated that 100 mu M of loureirin A almost completely eliminated collagen-induced Aid: phosphorylation at Ser473 interestingly, a submaximal (lose (50 mu M) of loureirin A had an additive inhibitory effect with the phosphoinositide 3-kinase (PI3K) inhibitor Ly294002 on collage-induced Akt phosphorylation in platelets. Taken together, loureirin A had an inhibitory effect on platelet activation, perhaps through an impairment of PI3K/Akt signaling, (C) 2014 Elsevier B.V. All rights reserved,